Changes in thrombolytic and inflammatory markers after initiation of indinavir- or amprenavir-based antiretroviral therapy

Author: Young Erika   Considine Robert   Sattler Fred   Deeg Mark   Buchanan Thomas   Degawa-Yamauchi Mikako   Shankar Sudha   Edmondson-Melançon Hannah   Hernandez Jaime   Dubé Michael  

Publisher: Humana Press, Inc

ISSN: 1530-7905

Source: Cardiovascular Toxicology, Vol.4, Iss.2, 2004-06, pp. : 179-186

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content